Jeff Yass’s Century Therapeutics IPSC Stock Holding History

Jeff Yass’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$284K	Sell	115,792 -110,895	-49%	-$253K	﹤0.01%	11174
2026 Q1	$512K	Buy	226,687 +176,583	+352%	+$371K	﹤0.01%	9599
2025 Q4	$49.8K	Sell	50,104 -17,820	-26%	-$10.9K	﹤0.01%	11750
2025 Q3	$33.8K	Sell	67,924 -132,027	-66%	-$71.2K	﹤0.01%	11955
2025 Q2	$112K	Buy	199,951 +142,516	+248%	+$76.5K	﹤0.01%	11721
2025 Q1	$27.3K	Buy	57,435 +24,040	+72%	+$18.1K	﹤0.01%	12038
2024 Q4	$33.7K	Buy	+33,395	New	+$45.5K	﹤0.01%	11813
2024 Q1	–	Sell	-22,629	Closed	-$75.1K	–	12720
2023 Q4	$75.1K	Buy	+22,629	New	+$41.2K	﹤0.01%	11516
2023 Q2	–	Sell	-10,747	Closed	-$37.3K	–	12596
2023 Q1	$37.3K	Buy	+10,747	New	+$47.2K	﹤0.01%	11826
2022 Q3	–	Sell	-14,152	Closed	-$149K	–	13643
2022 Q2	$119K	Buy	+14,152	New	+$139K	﹤0.01%	11289
2021 Q3	–	Sell	-23,001	Closed	-$675K	–	13137
2021 Q2	$675K	Buy	+23,001	New	+$584K	﹤0.01%	8834

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Jeff Yass's IPSC Position: Q2 2026 in Review

Jeff Yass reduced its Century Therapeutics (IPSC) stake by 49% in Q2 2026, selling an estimated $253K and leaving 115,792 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #11174.

Jeff Yass first reported a position in IPSC in Q2 2021 and has held it in 11 quarters since. The position peaked at $675K in Q2 2021. 98 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

Jeff Yass held 115,792 shares of Century Therapeutics worth $284K as of Q2 2026.
Jeff Yass sold 110,895 Century Therapeutics shares in Q2 2026, an estimated $253K.
Century Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11174 holding.
Jeff Yass first reported a position in Century Therapeutics in Q2 2021 and has held it in 11 quarters since.
Jeff Yass's Century Therapeutics position peaked at $675K in Q2 2021.
98 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.